ipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinomacorticosteroid therapy
…ase describes severe immune-mediated toxicity after one dose of ipilimumab (1 mg/kg) and nivolumab (3 mg/kg) in a stage IV patient who dev…